Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Zilucoplan in PNH
NCT03225287Phase 2Terminated
- Sponsor
- Ra Pharmaceuticals
- Start
- Jul 2017
- Primary completion
- Sep 2021
- Modality
- Cyclic Peptides
- Countries
- 8
01
Overview
A Phase 2 trial of zilucoplan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Ra Pharmaceuticals. Started Jul 2017; status: terminated.
02
Drugs
zilucoplan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT03225287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03225287.